A Phase 3 Clinical Study of KW-3357 in Patients With DIC

Summary

To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC criteria.

Timeline

Start

2012-02

Primary completion

2012-10

Completion

2012-10

Drugs

Indications